Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/216669
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bosch Amate, Xavier | - |
dc.contributor.author | Serra García, Laura | - |
dc.contributor.author | Alamon Reig, Francesc | - |
dc.contributor.author | Martí Martí, Ignasi | - |
dc.contributor.author | Gil Lianes, Javier | - |
dc.contributor.author | Giavedoni, Priscila | - |
dc.contributor.author | Mascaró Galy, José Manuel | - |
dc.date.accessioned | 2024-11-21T20:25:38Z | - |
dc.date.available | 2024-11-21T20:25:38Z | - |
dc.date.issued | 2022-08-01 | - |
dc.identifier.issn | 0004-8380 | - |
dc.identifier.uri | https://hdl.handle.net/2445/216669 | - |
dc.description.abstract | Granuloma annulare (GA) is a granulomatous, idiopathic, inflammatory skin disorder characterized by the formation of papules and plaques with annular and acral distribution. GA is often limited and self-resolving, but in some cases, it can be generalized and refractory to treatments. New advances in the pathophysiology of GA have favoured Janus kinase (JAK) inhibitors as a promising therapeutic option.1,2 Here, we report three cases of resistant generalized GA successfully treated with tofacitinib. | - |
dc.format.extent | 4 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Wiley | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1111/ajd.13875 | - |
dc.relation.ispartof | Australasian Journal of Dermatology, 2022, vol. 63, num.3, p. 400-403 | - |
dc.relation.uri | https://doi.org/10.1111/ajd.13875 | - |
dc.rights | cc-by (c) Bosch Amate, Xavier et al., 2022 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0 | * |
dc.source | Articles publicats en revistes (Medicina) | - |
dc.subject.classification | Malalties de la pell | - |
dc.subject.classification | Inhibidors enzimàtics | - |
dc.subject.classification | Resposta immunitària | - |
dc.subject.classification | Medicaments | - |
dc.subject.other | Skin diseases | - |
dc.subject.other | Enzyme inhibitors | - |
dc.subject.other | Immune response | - |
dc.subject.other | Drugs | - |
dc.title | Treatment of granuloma annulare with tofacitinib | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 751574 | - |
dc.date.updated | 2024-11-21T20:25:38Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 35605155 | - |
Appears in Collections: | Articles publicats en revistes (Medicina) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
870083.pdf | 1.98 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License